[] Responsible for annual strategic review cycle[] Led the preparation and execution of strategic divestment[] Steering an experienced team to build a robust 505(b)(2) injectables pipeline[] Assessing acquisition and restructuring opportunities along the value chain

Newly constituted business unit/region and role covering sales outside North America[] Formulated China entry plan with last resort antibiotics followed by B2B partner selection[] Introduced Xellia brand in middle east, developed go to market plan, selected partners[] Managing/ supporting contract negotiation in newly added markets, indications and businesses[] Supporting corporate with identification and evaluation of M&A and licensing opportunities

[] Developed 'Xellia 2.0', strategic plan for 2019+ marking shift in R&D pipeline and selling model [] De-/refined Xellia portfolio strategy; supported R&D in creating commercially attractive pipeline[] Managed divestment process for medical devices JV Pharmaero active in cystic fibrosis[] Corporate development focused on running a strategic merger project, divestment of assets, hiring and building portfolio team, developing processes/ templates, evaluation of investment cases, board updates and communication with novo holdings

Primarily with the anti-infective franchise (Holzkirchen) and B2B team (Kundl)[] Supported turnaround of franchise focusing on commercial engagements with country teams[] Established team, tools/processes to facilitate pricing, allocation, M&A and sourcing decisions[] Anchored go to market planning for biosimilar (Outside EU and NA)

Primarily worked on growth strategy, business transformation, feasibility assessment, M&A projectsSector focus on agro-chemicals, specialty chemicals, pharmaceuticals, FMCGSelect deliverable[] Accelerated India growth strategy for seeds and pesticide business of a global science company[] Designed manufacturing footprint and India distribution improvement plan for generic company[] Pre feasibility assessment including tendering process management for 2 billion $ project in SEA[] Market assessment and valuation of portfolio companies for IPO of a Middle East conglomerate

Primarily worked on supply chain, manufacturing, due diligence, transformation projectsSelect deliverable[] Manufacturing & supply chain transformation leading to ~3% margin gain for a large FMCG[] M&A projects including target identification, operational & commercial due diligence[] Retail strategy for a telecom operator leading to overhaul of store footprint & in-store experience

Developed risk assessment and pricing mechanism for new consulting engagements

[] Supply chain strategy, network footprint and production planning for a global FMCG[] Competitive benchmarking and Org. strategy for a SEA energy shipping companyPre placement offer at the end of internship

Focus on operational excellence and new projects[] High impact projects including assembly line installation, business development, contract manufacturing, productivity improvements and preparing blueprint for new factory[] Undertook plant layout optimization - Installed 2nd assembly line to increase output, achieved 30% reduction in handling, increased space utilization by 10%